Beyond Accelerated Approvals: External Control Arms
Hear this panel's discussion on the strategic use of external control arms and, if done correctly, how they can help bring products to market in a shorter time and for lower costs.
Debating the Value and Cost of AI Mammogram Analysis in Breast Cancer Detection
Radiology clinics offer artificial intelligence (AI) analysis of mammograms for $40, but insurance doesn't cover it. [...]
Total System Value™ – A DYNAMIC APPROACH TO VALUE DEMONSTRATION
HEOR Ltd. have been working on an exciting new framework called Total System Value™. This episode of tHEORetically speaking features their CEO Phil McEwan and CGO Jeff Anderson to talk to us about this dynamic approach to value demonstration.
Total System Value™ – A DYNAMIC APPROACH TO VALUE DEMONSTRATION
HEOR Ltd. have been working on an exciting new framework called Total System Value™. This episode of tHEORetically speaking features their CEO Phil McEwan and CGO Jeff Anderson to talk to us about this dynamic approach to value demonstration.
FDA Approves Florida’s Plan to Import Prescription Drugs from Canada
The Biden administration has approved Florida Governor Ron DeSantis' plan to import certain prescription drugs from [...]
AstraZeneca Acquires Obesity Drug Developer Eccogene’s ECC5004 for $185 Million, Aiming at Type 2 Diabetes and Obesity Markets
AstraZeneca is acquiring obesity drug developer Eccogene's ECC5004 for $185 million with the potential to pay [...]
Biden Administration Shifts COVID-19 Treatment Distribution to Private Sector
The Biden administration is transitioning the distribution of millions of COVID-19 treatments from the government to [...]
New FDA-Approved Non-Hormonal Treatment for Menopause: Challenges and Future of Veozah Accessibility
Veozah, a new treatment for hot flashes in menopausal women, was approved by the FDA in [...]
Pfizer Announces Cost-Cutting Measures as Covid Vaccine and Antiviral Sales Decline
Pfizer has announced plans for a company-wide cost-cutting initiative this year and next due to expected [...]
Reformative Health Economists Propose Universal, Free Basic Care in New Book
"We’ve Got You Covered: Rebooting American Health Care" is a new book by health economists Liran Einav and Amy Finkelstein. [...]
Federal Judge Upholds Medicare Drug Price Negotiation Provisions of Inflation Reduction Act
A federal judge has upheld the Medicare drug price negotiation provisions of the Inflation Reduction Act (IRA), opposing the Chamber [...]
American Medical Association Issues Unique PLA Code to Oxford BioDynamics
Oxford BioDynamics PLC has been assigned a unique Proprietary Laboratory Analysis Code (PLA Code) by the American Medical Association's CPT [...]
Johnson & Johnson’s Drug Combination Improves Progression-Free Survival in Lung Cancer Trial Against AstraZeneca’s Therapy
The Mariposa study showed that a combination of two Johnson & Johnson (J&J) drugs, Rybrevant, and lazertinib, was successful in [...]
Integration of Digital Targeting in Addressable TV: Implications for Healthcare Marketers
Addressable TV—which uses digital targeting and measurements for television advertisements—is changing the marketing landscape. It allows healthcare marketers to reach [...]
Plans to Remove Medical Debt from Credit Reports and Further Measures Proposed to Alleviate Medical Debt Burden
The White House has announced a plan by the Consumer Financial Protection Bureau (CFPB) to exclude [...]
Alexion Pharmaceuticals Nears $125M Settlement in Class Action Lawsuit Over Alleged Unethical Sales Practices
A 2016 class action lawsuit against pharmaceutical company Alexion, which claimed that the company's unethical sales [...]
Pharmaceutical Companies Sue Biden Administration Over Alleged APA Violations in Medicare Drug Pricing Program
Pharmaceutical companies, including AstraZeneca and Boehringer Ingelheim, are suing the Biden Administration over its plan to [...]
Medicare Price Negotiations for Drugs Begin in 2026: Eliquis Among Most Impacted
The Centers for Medicare & Medicaid Services (CMS) has disclosed a list of the initial ten drugs that will undergo [...]
Astellas Drops Lawsuit Against HHS Following Exclusion of Xtandi from Drug Price Negotiation List
Astellas has canceled its lawsuit against the U.S. Department of Health and Human Services (HHS) after its prostate cancer drug, [...]
Shortening Mental Health Treatment Waiting Times Could Save NHS Millions and Improve Patient Outcomes
What You Need to Know: Shortening treatment and waiting times for mental health conditions from 12 months to three could [...]
Dive Deep Into the Biden Administration’s Drug Price Negotiations
The Biden administration has announced the selection of 10 high-cost prescription drugs for price negotiations with pharma companies to help [...]
Medicare to Negotiate Prices for 10 High-Cost Drugs Under New Democratic Reform Law
Medicare will negotiate prices for ten high-cost drugs, including major diabetes medications and blood thinners, as part of a drug [...]
Danaher Acquires Life Sciences Supplier Abcam for $5.7 Billion
Danaher Corporation has announced the acquisition of Abcam, a UK-based life sciences supplier, for $5.7 billion. Abcam, a producer of [...]
Bruker to Acquire PhenomeX for $108M
Bruker Corporation is actively acquiring PhenomeX in a cash deal valued at $108 million. PhenomeX, a product of Berkeley Lights' [...]
Rising Biotech Stocks: Key Players to Monitor
10 Things You Need to Know: Biotech stocks continue to prosper long-term despite periodic fluctuations. In 2020, prominent biotech companies [...]
